Apo E gene polymorphism on development of diabetic nephropathy

dc.contributor.authorIlhan, Necip
dc.contributor.authorKahraman, Neslihan
dc.contributor.authorSeckin, Dilara
dc.contributor.authorIlhan, Nevin
dc.contributor.authorColak, Ramis
dc.date.accessioned2026-08-12T17:13:39Z
dc.date.issued2007
dc.departmentFırat Üniversitesi
dc.description.abstractType 2 diabetes causes premature morbidity and mortality due to the complications of atherosclerosis and diabetic nephropathy (DN). Polymorphism of Apo E gene is known to influence lipid metabolism. Apo E is polymorphic, consisting of three common isoforms (epsilon 2, epsilon 3 and epsilon 4) encoded by three alleles (2, 3 and 4) in exon 4 on chromosome 19. The aim of this study was to investigate the effect of Apo E polymorphism as a prognostic risk factor for the development of DN. A total of 108 NIDDM patients were recruited from the Nephrology and Endocrinology Departments of our hospital. All subjects were divided into three groups: Group I: diabetes with nephropathy (n:37), group II: diabetes without nephropathy (n:71), group III: controls (n:46). Apo E genotypes were determined by real-time PCR. The epsilon 4 allele frequency was significantly higher in-group I (10.8%) than in-group III (2.2%), (p < 0.05). In diabetics without nephropathy, the total cholesterol and LDL cholesterol levels were significantly lower in subjects with epsilon 2 alleles than epsilon 3 and epsilon 4 alleles. In conclusion, the present prospective study indicates that the epsilon 4 allele of the Apo E polymorphism is one of the prognostic risk factors involved in the development of DN with type 2 diabetes mellitus. Copyright (c) 2006 John Wiley & Sons, Ltd.
dc.identifier.doi10.1002/cbf.1348
dc.identifier.endpage532
dc.identifier.issn0263-6484
dc.identifier.issn1099-0844
dc.identifier.issue5
dc.identifier.orcid0000-0002-0208-8929
dc.identifier.orcid0000-0001-9997-0418
dc.identifier.orcid0000-0002-0208-8929
dc.identifier.pmid16933203
dc.identifier.scopus2-s2.0-34548768175
dc.identifier.scopusqualityQ3
dc.identifier.startpage527
dc.identifier.urihttps://doi.org/10.1002/cbf.1348
dc.identifier.urihttps://hdl.handle.net/11508/51518
dc.identifier.volume25
dc.identifier.wosWOS:000249634900009
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofCell Biochemistry and Function
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectdiabetic nephropathy
dc.subjectApo E gene polymorphism
dc.titleApo E gene polymorphism on development of diabetic nephropathy
dc.typeArticle

Dosyalar